clinical trials
clinical trials
Biomanufacturing Crisis: Demand Outstrips Capacity!
🌍 Explore the global capacity squeeze in biomanufacturing! 🏭 Demand skyrockets, creating challenges and the need for strategic partnerships. 🤝✨
Oxford and ReciBioPharm Join Forces Against Malaria!
🌍 Exciting collaboration! University of Oxford and ReciBioPharm advance malaria vaccine development with promising candidates R78C and RH5.1! 💉🔬🧬
Exogenus and Lonza Team Up for Groundbreaking Therapy!
🌟 Exogenus Therapeutics partners with Lonza for GMP-compliant Exo-101 process. Promising treatment for tissue regeneration and inflammation! 🔬🤝
Revolutionary Cancer Drug Biosimilar Nears Trials!
**Excerpt:** 🌟 Scientists are developing a biosimilar for atezolizumab using CHO DG44 cells, showing promising effectiveness in cancer treatment! 🔬🧪📈
2025: Breakthroughs and Challenges in Gene Therapy
🚀 Discover the future of cell and gene therapy in 2025! 🌟 Exciting advances, ongoing trials, and a free summit await! 💉📅🎉
Revolutionizing EV Production: Immortalized hMSCs in Suspension!
**Excerpt:** 🌟 Discover how adapting immortalized hMSCs to suspension culture revolutionizes EV production, boosting scalability and reducing costs! 🚀💡🔬
Boosting Biosimilar Efficiency with Cutting-Edge Technologies
📢 Biosimilar manufacturers are seeking more efficient technologies to reduce costs and increase drug availability. 🔬⚠️💡🔑🌍
Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪
Revolutionizing Oral Biologic Delivery: Tiny VHH Antibodies
🔍 Discover how VHH antibodies could revolutionize oral delivery of biologics, overcoming challenges for better absorption and stability.
Entos Pharmaceuticals Expands Manufacturing Powerhouse
📢 Entos Pharmaceuticals opens GMP facility in Carlsbad, CA to support studies and trials, advancing pipeline of 20 programs. 🔬💰🌎
